![γ-Secretase inhibitors for breast cancer and hepatocellular carcinoma: From mechanism to treatment - ScienceDirect γ-Secretase inhibitors for breast cancer and hepatocellular carcinoma: From mechanism to treatment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0024320520317677-gr1.jpg)
γ-Secretase inhibitors for breast cancer and hepatocellular carcinoma: From mechanism to treatment - ScienceDirect
![γ-secretase inhibitors, DAPT and RO4929097, promote the migration of Human Glioma Cells via Smad5-downregulated E-cadherin Expression γ-secretase inhibitors, DAPT and RO4929097, promote the migration of Human Glioma Cells via Smad5-downregulated E-cadherin Expression](https://www.medsci.org/v18/p2551/toc.jpg)
γ-secretase inhibitors, DAPT and RO4929097, promote the migration of Human Glioma Cells via Smad5-downregulated E-cadherin Expression
![Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance - McCaw - 2021 - The Oncologist - Wiley Online Library Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance - McCaw - 2021 - The Oncologist - Wiley Online Library](https://theoncologist.onlinelibrary.wiley.com/cms/asset/b6960ac1-693a-4f3b-9dd3-e5d0a8d93933/onco13627-fig-0001-m.jpg)
Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance - McCaw - 2021 - The Oncologist - Wiley Online Library
![γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct | EMBO Molecular Medicine γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/1868f81f-f9d8-44b2-8388-9a11ea18ebec/emmm201607265-abs-0001-m.jpg)
γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct | EMBO Molecular Medicine
![Alzheimer's disease-associated mutations increase amyloid precursor protein resistance to γ-secretase cleavage and the Aβ42/Aβ40 ratio | Cell Discovery Alzheimer's disease-associated mutations increase amyloid precursor protein resistance to γ-secretase cleavage and the Aβ42/Aβ40 ratio | Cell Discovery](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fcelldisc.2016.26/MediaObjects/41421_2016_Article_BFcelldisc201626_Fig1_HTML.jpg)
Alzheimer's disease-associated mutations increase amyloid precursor protein resistance to γ-secretase cleavage and the Aβ42/Aβ40 ratio | Cell Discovery
![Frontiers | Targeting Amyloidogenic Processing of APP in Alzheimer's Disease | Molecular Neuroscience Frontiers | Targeting Amyloidogenic Processing of APP in Alzheimer's Disease | Molecular Neuroscience](https://www.frontiersin.org/files/Articles/558862/fnmol-13-00137-HTML-r1/image_m/fnmol-13-00137-g001.jpg)
Frontiers | Targeting Amyloidogenic Processing of APP in Alzheimer's Disease | Molecular Neuroscience
![The γ-secretase inhibitors used in clinical trial for the treatment of... | Download Scientific Diagram The γ-secretase inhibitors used in clinical trial for the treatment of... | Download Scientific Diagram](https://www.researchgate.net/profile/Adolfo-Poma-2/publication/355137849/figure/fig3/AS:1076859450195970@1633754708845/The-g-secretase-inhibitors-used-in-clinical-trial-for-the-treatment-of-AD-and-taken-from.jpg)
The γ-secretase inhibitors used in clinical trial for the treatment of... | Download Scientific Diagram
![g-Secretase inhibitors recently or currently in clinical trials for the... | Download Scientific Diagram g-Secretase inhibitors recently or currently in clinical trials for the... | Download Scientific Diagram](https://www.researchgate.net/profile/Bart-Strooper/publication/221815851/figure/fig4/AS:601671554048008@1520461085119/g-Secretase-inhibitors-recently-or-currently-in-clinical-trials-for-the-treatment-of.png)
g-Secretase inhibitors recently or currently in clinical trials for the... | Download Scientific Diagram
![γ-Secretase inhibitors for breast cancer and hepatocellular carcinoma: From mechanism to treatment - ScienceDirect γ-Secretase inhibitors for breast cancer and hepatocellular carcinoma: From mechanism to treatment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0024320520317677-gr2.jpg)
γ-Secretase inhibitors for breast cancer and hepatocellular carcinoma: From mechanism to treatment - ScienceDirect
![PDF) Three cases of apparent Vasogenic Edema (VE) from a phase 2 clinical trial of the gamma secretase Inhibitor BMS-708163 in patients with mild-to-moderate AD | Mark Meadowcroft and charles e albright - PDF) Three cases of apparent Vasogenic Edema (VE) from a phase 2 clinical trial of the gamma secretase Inhibitor BMS-708163 in patients with mild-to-moderate AD | Mark Meadowcroft and charles e albright -](https://0.academia-photos.com/attachment_thumbnails/42245696/mini_magick20190217-11029-n5b0pz.png?1550474696)